Clinical studies have recently started in Southeast Asia and Latin America. “It is necessary that middle- and lower-income states also have access to a vaccine,” says Palese, who sees this as an alternative to the doses of other developers, which cost up to $ 50. Palese is the director of the Mount Sinai School of Medicine. The virologist Florian Krammer, who comes from Styria and also works in New York, is also involved in the development.
Compared to the pharmaceutical companies, which have made incredible leaps in a very short time with financial support from politicians, the prerequisites for his team are of course different, says Palese. Initial studies have shown that the one-dollar vaccine can build a good immune response.
turned_in
info With a click on the icon you add the keyword to your topics.
–
turned_in
info
Click on the icon to open your “my topics” page. They have of 15 keywords saved and would have to remove keywords.
–
turned_in
info By clicking on the icon, you can remove the keyword from your topics.
–
turned_in
Add the subject to your subjects.
–
–
–
